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Background: The spread of carbapenem resistant Enterobacteriaceae (CRE) is an emerging clinical problem, of great
relevance in Europe and worldwide. The aim of this study was the molecular epidemiology of CRE isolates in Valle
d’Aosta region, Italy, and the mechanism of carbapenem resistance.
Results: Sixty consecutive CRE samples were isolated from 52 hospital inpatients and/or outpatients from
November 2013 to August 2014. Genotyping of microbial isolates was done by pulsed-field gel electrophoresis (PFGE)
and multi-locus sequence typing (MLST), carbapenemases were identified by PCR and sequencing. Carbapenem
resistance gene transfer was performed by filter mating, plasmids from parental and transconjugant strains were
assigned to incompatibility groups by PCR-based replicon typing. Molecular characterization of CRE isolates assigned
25 Klebsiella pneumoniae isolates to PFGE types A1-A5 and sequencing type (ST) 101, 17 K. pneumoniae isolates to PFGE
type A and ST1789 (a single locus variant of ST101), 7 K. pneumoniae isolates to PFGE types B or C and ST512,
2 K. pneumoniae isolates to PFGE type D and ST405, and 5 Escherichia coli isolates to PFGE type a and ST131.
All K. pneumoniae ST101 and ST1789 isolates were extended-spectrum beta-lactamase (ESBL) producers and
carried blaCTX-M-1 group gene; 4 K. pneumoniae ST101 isolates were resistant to colistin. Molecular analysis of
beta-lactamase genes identified blaKPC-2 and blaCTX-M-group 1 into conjugative plasmid/s assigned to IncFII incompatibility
group in ST101 and ST1789 K. pneumoniae isolates, blaKPC-3 into conjugative plasmid/s assigned to IncF incompatibility
group in ST512 and ST405 K. pneumoniae isolates, blaVIM-1 into conjugative plasmid/s assigned to IncN incompatibility
group in ST131 E. coli isolates.
Conclusions: The spread of CRE in Valle d’Aosta region was caused by the selection of KPC-2 producing K. pneumoniae
ST101 and ST1789 epidemic clones belonging to clonal complex 101, KPC-3 producing K. pneumoniae epidemic clones
assigned to ST512 and ST405, and VIM-1 producing E.coli ST131 epidemic clone. Carbapenem resistance, along
with blaKPC-2, blaKPC-3 and blaVIM-1 carbapenemase genes, was transferred by conjugative plasmids assigned to IncFII,
IncF, and IncN incompatibility groups, respectively, in filter mating experiments. The emergence of colistin resistance
was observed in KPC-2 producing K. pneumoniae ST101 isolates.
Keywords: Epidemiological typing, Carbapenem resistant Enterobacteriaceae, Carbapenemase, Horizontal gene transfer* Correspondence: rafzarri@unina.it
†Equal contributors
1Department of Public Health, University of Naples ‘Federico II’, Naples, Italy
4CEINGE Biotecnologie Avanzate, Naples, Italy
Full list of author information is available at the end of the article
© 2015 Del Franco et al. Open Access This ar
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Del Franco et al. BMC Microbiology  (2015) 15:260 Page 2 of 9Background
The spread of resistance to carbapenems among Enterobac-
teriaceae has become a major public health problem. In
fact, epidemics or endemic conditions of patients infected
or colonized by Enterobacteriaceae non susceptible to car-
bapenems has been reported in the hospital and in the
community setting [1–3]. Carbapenem resistant Enterobac-
teriaceae (CRE) are resistant to most β-lactams, including
the carbapenems, and frequently carry additional anti-
microbial resistance genes to other non-β-lactam antibi-
otics, which render them resistant to most antibiotics [1–3].
Two main mechanisms are responsible for carbapenem
resistance in Enterobacteriaceae: reduced outer membrane
permeability by porin loss in combination with the pro-
duction of an extended spectrum beta-lactamase or of
AmpC-type beta-lactamase; and the production of beta-
lactamases capable of hydrolysing carbapenems (carbape-
nemases) [1–3]. Because acquired carbapenemases are
encoded by transferable genes located in mobile elements
such as plasmids and transposons, which may disseminate
among different strains and species, carbapenemase-
mediated resistance represents the major treat in CRE
[1–6]. The occurrence of either class B metallo-beta-
lactamases (IMP, VIM, NDM) or classes A (KPC) and D
(OXA-48) serine carbapenemases have been reported in
Europe and world-wide [1–6]. In Italy, Enterobacteriaceae
producing VIM-type enzymes and more recently KPC-
type enzymes have been described [7–10]. The increase of
carbapenem resistance in Enterobacteriaceae has been
sustained also by the selection of multidrug-resistant high
risk clonal lineages, which successfully propagated in the
hospital and the community settings [6, 11]. Also, the
coexistence of carbapenem resistance and extended-
spectrum beta-lactamase (ESBL) production has been
frequently described [2, 12–14]. Moreover, the move-
ment of colonized patients, mainly elderly, between
hospital wards and long-term care settings may con-
tribute to the spread of CRE [1–3, 8].
To control the spread of CRE in health care facil-
ities and the transmission of CRE among patients,
guidelines have been established from European
Centre for Disease Prevention and Control for the
screening and identification of CRE isolates among
colonized patients [15], which have been adopted in
Italy, both at regional and national level [16].
The aim of the current study was to analyze the molecu-
lar epidemiology of 60 consecutive CRE in the hospital
wards and long-term care facilities of the USL Valle
d’Aosta, and the mechanism of carbapenem resistance.
Methods
Setting and study period
Valle d’Aosta is the smallest region of Italy (3262 sq
Kms), entirely located in the north western Alps region;there is one health agency and only one public Hospital,
with 480 beds: there is one microbiology laboratory that
processes samples from both Hospital and the territory.
Moreover, a network of about 45 long-term care resi-
dencies for elders is distributed over the territory, ac-
counting for another 1000 beds. The present study
analyzed 60 consecutive isolates of CRE from 52 hos-
pital inpatients and/or outpatients who were admitted
to the USL Valle d’Aosta between November 2013
and August 2014.
Surveillance of CRE Enterobacteriaceae
Surveillance of CRE was performed according to
European Centre for Disease Prevention and Control
[15] and the Ministero della Salute, Italy [16]. Surveil-
lance and infection control measures adopted for CRE
positive patients included: rectal swab screening of
both hospital inpatients and outpatients; isolation and
cohorting of CRE positive hospital inpatients; recall
and screening of CRE positive outpatients.
Bacterial strains and microbiological methods
All the Enterobacteriaceae isolates were identified using
the Vitek 2 automatic system and the ID-GNB card for
identification of Gram-negative bacilli according to the
manufacturer’s instructions (bio-Merieux, Marcy l’Etoile,
France). Two Raoultella spp., and one Enterobacter spp.
were further identified as R. planticola, R. ornithinolytica
and E. aerogenes by amplification and sequencing of the
rpoB gene as previously described [17].
Antimicrobial susceptibility testing
Carbapenem resistance of Enterobacteriaceae was screened
using the meropenem disk alone as previously described
[18]. Susceptibility tests were performed using the Vitek 2
system and the AST-GN card (bioMe’rieux). Breakpoints
values were those recommended by the EUCAST 2014
[19]. Escherichia coli ATCC 25922 was used as quality con-
trol strain. ESBL activity was evaluated using the
double-disk synergy test as previously described [20].
Colistin susceptibility was evaluated by broth microdi-
lution in Mueller–Hinton broth II (MHBII) according
to Clinical and Laboratory Standards Institute guide-
lines [21].
Molecular analysis of antimicrobial resistance genes
All the isolates were subjected to polymerase chain re-
action (PCR) to screen for the presence of blaKPC,
blaIMP, blaVIM, blaNDM and blaOXA-48, as described pre-
viously [22]. Acinetobacter baumannii AC 54/97 [23],
A. baumannii 161/07 [24] and Klebsiella pneumoniae
D001 [18] were used as positive quality control strains
for blaIMP-2, blaNDM-1 and blaOXA-48 carbapenemase
genes, respectively. The presence of the correct size
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esis. The full-length alleles of blaKPC and blaVIM were
amplified using primers KPC-F2: GTATCGCCGTCT
AGTTCTGC and KPC-Rm: CTTGTCATCCTTGTTA
GGCG, primers 5’VIM1: ATGTTAAAAGTTATTAGT
AGTT and 3’VIM1: CTACTCGGCGACTGAGCGATT,
respectively. Direct sequencing of PCR products was
performed using the ABI Prism BigDye Terminator
v3.1 Ready Reaction cycle sequencing kit and the 3730
DNA analyzer (Applied Biosystems, Foster City, CA).
Nucleotide sequences obtained were compared with the
deduced amino acid sequence available in GenBank
using tblastx [25]. The presence of blaCTX-M extended-
spectrum beta-lactamase genes was investigated by
multiplex PCR as described previously [26]. Escherichia
coli SGH 20-ADM was used as positive quality control
strain for blaCTX-M-15 gene [27]. The presence of the
armA methylase gene was investigated by PCR using
specific primers as described previously [28].PFGE typing and dendrogram analysis
XbaI DNA macrorestriction of Enterobacteriaceae iso-
lates was performed as previously reported [29]. PFGE
conditions were as follows: pulse times ranged from 5 to
40 s over 24 h at6 · 0 V/cm and at 14C. The PFGE pro-
files obtained were converted to TIFF files and subjected
to cluster analysis using the GelCompare II v. 4.6 soft-
ware package (AppliedMaths, Sint-Martens-Latem,
Belgium). Clustering was based on the unweighted pair-
group method with arithmetic averages (UPGMA). The
Dice correlation coefficient was used to analyze the simi-
larities of the banding patterns with a tolerance of 1.5 %.
The interpretation of chromosomal DNA restriction
patterns was based on the criteria of Tenover et al. for
closely related isolates [30]. Briefly, strains showing
more than three DNA fragment variations and a simi-
larity of <85 % at dendrogram analysis were considered
to represent different PFGE types, while one to three-
fragment differences and a similarity of >85 % upon
dendrogram analysis were considered to represent
PFGE pattern subtypes.MLST analysis
MLST analysis of K. pneumoniae isolates was per-
formed using the Institut Pasteur’s MLST scheme
[31]. The allele sequences and sequence types (STs)
were identified at http://bigsdb.web.pasteur.fr/klebsi-
ella/klebsiella.html. MLST analysis of E. coli isolates
was performed as previously described [32, 33], with
the following minor modifications for annealing tem-
peratures of the primers, respectively 54 °C for adk,
fumC and icd genes, 58 °C for recA and mdh genes,
60 °C for purA gene, and 64 °C for gyrB gene. Allelesequence and MLST profile definitions were identified
at http://mlst.warwick.ac.uk/mlst/dbs/Ecoli.
Conjugative transfer of carbapenem resistance and
plasmid typing
Conjugation experiments were performed by filter
mating experiments as previously described [34] using
sodium-azide resistant E. coli J53 [35] as recipient
strain on BHI agar plates in the presence of 16 mg/l
imipenem and 100 mg/l sodium-azide. The frequency
of transfer was calculated as the number of transcon-
jugants divided by the number of surviving recipients.
Plasmids from parental and transconjugant strains
were assigned to incompatibility groups by PCR-based
replicon typing (PBRT-kit) (Diatheva s.r.l., Fano, Italy)
performed on total DNA using previously described
primers and conditions [36, 37].
Ethical approval
The study was approved by the ethics committee of the
Aosta Regional Hospital (protocol number 836/2015).
All microbiological samples were taken as part of stand-
ard care procedures. No written informed consent was
necessary for this type of study.
Results
CRE isolates included in the study
The molecular epidemiology of carbapenem-resistant
Enterobacteriaceae was studied in the Valle d’Aosta
region from November 2013 to August 2014. During
this period, 60 consecutive CRE were isolated from
52 different patients, both from clinical samples and
from surveillance screening. Of these patients, 6 were
outpatients, 4 were admitted to nursing homes, while
the remaining 42 were admitted to hospital’s internal
wards (in particular, 19 in geriatrics, 4 in intensive
care, 4 in neurology, 10 in medical departments and
5 in surgical wards). The isolated materials were 32
urine culture, 20 rectal swabs, 3 respiratory secretions, 2
blood culture, 1 liquid drainage, 1 peritoneal-fluid,
and 1 wound swab. Fifty-one isolates were identified
as K. pneumoniae, 6 were E. coli, 1 R. planticola, 1 R.
ornithinolytica, and 1 E. aerogenes (Figs. 1 and 2 and
Additional file 1: Table S1).
Antimicrobial susceptibility patterns of Enterobacteriaceae
isolates
Both K. pneumoniae and E. coli isolates showed a
multidrug-resistant antibiotype. In particular, they were re-
sistant to imipenem, meropenem, ertapenem, beta-lactam/
beta-lactamase inhibitor combinations (clavulanic acid/
amoxicillin, piperacillin/tazobactam), third and fourth gen-
eration cephems, fluoroquinolones (ciprofloxacin), and
trimethoprim-sulfamethoxazole; 38K. pneumoniae isolates
Fig. 1 Genotypic analysis of carbapenem resistant K. pneumoniae isolates. Dendrogram analysis of digitized XbaI PFGE profiles of carbapenem
resistant K. pneumoniae isolates is shown. Percentage of similarity at dendrogram analysis and sizes in kilobases (kb) of lambda DNA
molecular mass markers are indicated above dendrogram and PFGE profiles, respectively. Isolate number, taxonomic identification, source,
date of isolation, patient name, ward, PFGE type, MLST sequence type and carbapenemase are shown also. UC, urine culture; RS, rectal swab;
WS, wound swab; DL, drainage liquid; EMO, blood culture; PF, peritoneal fluid; BA, bronchial aspirate; PFGE, pulsed-field gel electrophoresis; MLST,
multilocus sequence typing; ST, sequence type
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ceptible to aminoglycosides (amikacin and gentamicin);
46 K. pneumoniae isolates were resistant but 5 K. pneu-
moniae isolates were susceptible to fosfomycin; all E.
coli isolates were susceptible to aminoglycosides and
fosfomycin. Also, 42 K. pneumoniae isolates were iden-
tified as ESBL producers (Table 1 and Additional file 1:
Table S1). Interestingly, all E. coli isolates and the ma-
jority of K. pneumoniae isolates were susceptible to co-
listin, but 4 K. pneumoniae isolates were resistant to
colistin, minimal inhibitory concentrations (MICs) 16–
125 mg/l (Table 1 and Additional file 1: Table S1).
Raoultella spp and E. aerogenes isolates were resistant
to carbapenems, beta-lactam/beta-lactamase inhibitor
combinations, third and fourth generation cephems,
fluoroquinolones and trimethoprim-sulfamethoxazole
but susceptible to aminoglycosides, fosfomycin and co-
listin (Additional file 1: Table S1).Molecular analysis of antimicrobial resistance genes of
CRE isolates
PCR and sequence analysis of carbapenemase genes identi-
fied blaVIM-1 in 5 E.coli isolates, blaKPC-2 in 42K. pneumo-
niae and 1 R. planticola isolates, and blaKPC-3 in 9K.
pneumonia isolates. No carbapenemase genes were identi-
fied in 1 R. ornithinolytica, 1 E. coli, and 1 E. aerogenes
isolate (Figs. 1 and 2 and Additional file 1: Table S1). Also,
blaCTX-M-1 group gene was amplified from all 42 ESBL-
producing K. pneumoniae isolates; armA gene was amplified
from all 38 K. pneumoniae isolates resistant to amino-
glycosides but not from 13 K. pneumoniae isolates sus-
ceptible to aminoglycosides (Additional file 1: Table S1).
Molecular epidemiology of CRE isolates in the USL Valle
d’Aosta
To investigate whether the isolation of CRE during the
study period was caused by the spread of epidemic
Fig. 2 Genotypic analysis of carbapenem resistant E. coli isolates. Dendrogram analysis of digitized XbaI PFGE profiles of carbapenem
resistant E. coli isolates is shown. Percentage of similarity at dendrogram analysis and sizes in kilobases (kb) of lambda DNA molecular
mass markers are indicated above dendrogram and PFGE profiles, respectively. Isolate number, taxonomic identification, source, date of
isolation, patient name, ward, PFGE type, MLST sequence type and carbapenemase are shown also. UC, urine culture; RS, rectal swab; WS,
wound swab; DL, drainage liquid; EMO, blood culture; PF, peritoneal fluid; BA, bronchial aspirate; PFGE, pulsed-field gel electrophoresis;
MLST, multilocus sequence typing; ST, sequence type
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typing by PFGE identified four major PFGE types in 51
K. pneumoniae isolates, which we categorized from A to
D. Of the 42 K. pneumoniae isolates assigned to major
PFGE type A, 17 isolates showed an identical macrores-
triction pattern (PFGE type A), while 25 strains differed
in the migration of one or two DNA fragments and were
classified into subtypes A1-A5 (Fig. 1). PFGE types E
and F were assigned to R. ornithinolytica and R. planti-
cola isolates, respectively (data not shown). Also, PFGE
analysis identified identical macrorestriction pattern
(PFGE type “a”) in 5 E. coli isolates and PFGE types “b”
and “c”, which differed in the migration of more than 3
bands, in 1 E. coli and 1 E. aerogenes isolate, respectivelyTable 1 Antibiotic susceptibility profiles of carbapenem resistant K.
MICa (mg/l)
















aMIC, minimal inhibitory concentration(Fig. 2). Genotype analysis using MLST identified ST101
for K. pneumoniae isolates assigned to PFGE subtypes
A1-A5 and a novel ST1789 for K. pneumoniae isolates
assigned to PFGE type A. Because ST101 and ST1789
were single locus variants, they were clustered in the
same clonal complex (CC) 101 by eBURST analysis. On
the contrary, MLST identified ST512 for K. pneumoniae
isolates assigned to PGFE types B and C and ST405 for
K. pneumoniae isolates assigned to PGFE type D. ST512
and ST405 differed by at least two loci from all other
profiles found in the population under analysis and were
regarded as singletons (Fig. 1). Based on all the above
data, four distinct epidemic genotypes were identified in
K. pneumoniae isolates, which we named ST1789/A,pneumoniae and E. coli
E. coli (6 total strains)
Range MIC50 MIC90 Range
16 - ≥ 32 ≥32 ≥32 ≥32
≥128 ≥128 ≥128 ≥128
>4 - ≥ 64 ≥64 ≥64 ≥64
8 - ≥ 64 ≥64 ≥64 ≥64
>4 - ≥ 64 ≥64 ≥64 ≥64
>8 - ≥ 16 ≥16 ≥16 ≥16
≥16 ≥16 ≥16 >8 -≥ 16
4 - ≥ 8 >1 2 >1 - 2
≤16 - ≥ 256 ≤16 ≤16 ≤16
≤2 - ≥ 64 ≤2 ≤2 ≤2
≤1 - ≥ 16 2 2 ≤1- 2
>1 - ≥ 4 ≥4 ≥4 ≥4
≤20 - ≥ 320 ≥320 ≥320 ≤20 - ≥ 320
≤0,5 - 125 ≤0,5 ≤0,5 ≤0,5
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MLST analysis identified ST131 for all E. coli isolates
assigned to PFGE type “a” and subtype “a1”, which we
named ST131/a epidemic genotype (Additional file 1:
Table S1). All K. pneumoniae isolates assigned to ST101/
A1-A5 and ST1789/A epidemic genotypes were ESBL
producers and carried blaCTX-M-1 group gene. Also, 23 of
25 K. pneumoniae isolates assigned to ST101/A1-A5 epi-
demic genotype, 8 of 17 K. pneumoniae isolates assigned
to ST1789/A epidemic genotype, and all K. pneumoniae
isolates assigned to ST512/B-C epidemic genotype car-
ried armA gene and were resistant to aminoglycosides
(Tables S1). Four K. pneumoniae isolates assigned to
ST101/A1-A5 epidemic genotype were resistant to colis-
tin (Additional file 1: Table S1).
To further study the mechanism responsible for carba-
penem resistance, we asked whether carbapenem resist-
ance might have been transferred through conjugation.
Resistance to imipenem and meropenem (MIC ≥16 mg/l)
and ESBL activity along with blaKPC-2 and blaCTX-M-group 1
was transferred from K. pneumoniae isolates assigned to
genotypes ST1789/A and ST101/A1 to E. coli J53 strain at
frequencies ranging from 8.3 × 10−4 to 1.4 × 10−6 cfu/re-
cipient cells. Also, resistance to imipenem and merope-
nem (MIC ≥16 mg/l) along with blaKPC-3 or blaVIM-1 was
transferred from K. pneumoniae isolates assigned to geno-
types ST512/B, ST512/C, ST405/D and E. coli isolate
assigned to genotype ST131/a, respectively, to E. coli
J53 at frequency ranging from 2.5 × 10−2 to 2.5 × 10−7
cfu/recipient cells. All transconjugants were resistant
to sodium-azide and showed a PFGE profile identical
with that of the recipient strain (Table 2). Also, we
asked whether conjugative plasmids were responsible
for the horizontal transfer of carbapenem resistance.
PCR-based replicon typing identified FII replicon and
IncFII incompatibility group plasmid/s in ESBL positive
and carbapenem-resistant K. pneumoniae isolates and
transconjugants producing blaKPC-2 and blaCTX-M-group 1
genes, while FIIk replicon and IncF incompatibility groupTable 2 Conjugative transfer of carbapenem resistance in Enterobac
Strain number Donor Genotypea Transconjugant Genotypea Frequen
5:J53 ST1789/A ST10/d 8.3×10−
8:J53 ST101/A1 ST10/d 1.4 × 10
2:J53 ST512/B ST10/d 6.8 × 10
12:J53 ST512/C ST10/d 2.5 × 10
24:J53 ST405/D ST10/d 1.6 × 10
6:J53 ST131/a ST10/d 2.5 × 10
J53 ST10/d ST10/d -
aThe genotypes of the strains were identified by MLST sequencing types (STs) and
described in the methods section
bMating rate was calculated as frequency of carbapenem resistant transconjugants
cReplicon typing was performed as describe in the materials and method section
dESBL (extended-spectrum beta-lactamase)plasmid/s in K. pneumoniae isolates and transconjugants
producing blaKPC-3 gene. Moreover, the E. coli donor
strain expressing blaVIM-1 gene and its transconjugant
were shown to carry plasmid/s with N replicon and IncN
incompatibility group (Table 2).
Molecular epidemiology of CRE isolates showed that
the increase of CRE was caused by the spread of
KPC-2 producing K. pneumoniae ST101/A1-A5 and
ST1789/A epidemic genotypes, which belonged to the
same CC101. In particular, 17 KPC-2 producing K.
pneumoniae assigned to ST1789/A were isolated from
17 patients; 25 KPC-2 producing K. pneumoniae
assigned to ST101/A1-A5 genotype were isolated
from 21 patients, 3 patients showing repetitive isola-
tion of K. pneumoniae ST101/A1-A3, one of which
having isolation of K. pneumoniae ST101/A1-A3 in
neurology ward and one month later as outpatient.
Also, 2 patients showed isolation of ST1789/A and
ST101/A2-A3. Seven KPC-3 producing K. pneumoniae
ST512/B-C, 2 KPC-3 producing K. pneumoniae
ST405/D, and 5 VIM-1 producing E. coli ST131/a
were isolated from 7, 2, and 5 patients, respectively.
Two different patients showed the isolation of ST512/
B1 and ST405/D, and ST101/A1 and ST131/a (Fig. 1).
As shown in Fig. 3, KPC-2 producing K. pneumoniae
ST1789/A were isolated from 6, 5, 4 and 1 patients in
nursing homes, geriatrics, medical wards, neurology, re-
spectively, and 1 outpatient; KPC-2 producing K. pneumo-
niae ST101/A1-A5 were isolated from 12, 3, 2, 2, and 1
patients in geriatrics, neurology, intensive care unit, med-
ical and surgical wards, respectively and in 5 outpatients
(Fig. 3). KPC-3 producing K. pneumoniae ST512/B-C,
ST405/D, and VIM-1 producing E. coli ST131/a epidemic
genotypes were isolated from 2 patients in intensive care
unit and 5 and 4 patients in medical and surgical wards,
respectively; KPC-3 producing K. pneumoniae ST405/D
and VIM-1 producing E. coli ST131/a genotypes were
isolated from 3 patients in geriatrics and 2 outpatients, re-
spectively (Fig. 3).teriacea
cy of transferb Replicon typingc ESBLd Carbapenemase
4 FII CTX-M-1 group KPC-2
−6 FII CTX-M-1 group KPC-2
−5 FIIk - KPC-3
−7 FIIk - KPC-3
−5 FIIk - KPC-3
−2 N - VIM-1
- - -
PFGE types. Different MLST schemes were used for K. pneumoniae and E. coli as
for recipient cell resistant to sodium-azide in filter mating experiments
Fig. 3 Molecular epidemiology of CRE in the USL Valle d’Aosta. Circulation of CRE epidemic genotypes in the USL Valle d’Aosta, from November
2013 to August 2014. The number of CRE clinical isolates and wards are shown
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In the present report, we studied the molecular epi-
demiology and the genetic basis of carbapenem resist-
ance in CRE isolates in the USL Valle d’Aosta between
November 2013 and August 2014. In accordance with
previous data [1–7, 9, 10], the spread of CRE in Valle
d’Aosta region was caused by the selection of few epi-
demic distinct genotypes of KPC-2 producing K. pneu-
moniae, KPC-3 producing K. pneumoniae, or VIM-
producing E. coli. The majority of the isolates (42 of 60)
were assigned to K. pneumoniae ST101/A1-A5 and
ST1789/A genotypes, which belonged to the same CC101
and carried blaKPC-2 into IncFII conjugative plasmid/s.
KPC-2 producing K. pneumoniae ST101/A1-A5 were iso-
lated from patients in geriatrics, neurology, other medical
wards, and from outpatients; KPC-2 producing K. pneu-
moniae ST1789/A were isolated from patients in geriat-
rics, medical wards, nursing homes, and one outpatient.
The isolation of identical genotypes of CRE in long-term
care facilities and adjacent hospital wards is in agreement
with a previous study showing the isolation of identical
carbapenemase among Enterobacteriaceae in an Italian
tertiary-care hospital and adjacent long-term care facilities
[8]. KPC-2 producing K. pneumoniae ST101 has already
been reported as sporadic isolation in Brazil [38] and spor-
adic or epidemic isolation in Italy [9, 39–41], while KPC-2
producing K. pneumoniae ST1789 and nosocomial out-
break caused by KPC-2 producing K. pneumoniae ST101
and ST1789 belonging to CC101 were described for the
first time herein. Also, sporadic isolation of KPC-3 produ-
cing K. pneumoniae ST101 has been reported in Southern
Italy [42], thus suggesting that blaKPC-2 might have been
acquired through horizontal gene transfer. In furthersupport of this hypothesis, we demonstrated herein that
K. pneumoniae ST101 and ST1789 isolates carried blaKPC-
2 into IncFII conjugative plasmid/s. We also observed
the spread of KPC-3 producing K. pneumoniae ST512/
B and ST512/C genotypes. Because K. pneumoniae
ST512 is a single locus variant of ST258, KPC-3 produ-
cing K. pneumoniae ST512 isolates can be assigned to
the multidrug-resistant high risk CC-258, which was re-
sponsible of several epidemics in Europe and Italy [6, 9, 11,
42]. Our data showed also the spread of VIM-1 producing
E. coli ST131 among CRE isolates. This is consistent with
previous studies showing the emergence of hypervirulent
E. coli ST131 clonal lineage [6] and VIM-like producing
CRE in Europe and Northern Italy [4, 6–8, 10].
Several studies demonstrate that epidemic clones of
CRE are selected in the community and hospital set-
ting because of their multiple antimicrobial resis-
tances [1–11]. The presence of carbapenemases and
the acquisition of carbapenemases through horizontal
gene transfer have been frequently reported [1–7].
Accordingly, our data showed that carbapenem resist-
ance, along with blaKPC-2, blaKPC-3 and blaVIM-1 car-
bapenemase genes carried by conjugative plasmids
assigned to IncFII, IncF, and IncN incompatibility
groups, respectively, was transferred by filter mating
experiments. Interestingly, blaKPC-3 carried by conju-
gative plasmid/s assigned to IncF incompatibility
group was found in both K. pneumoniae ST512 and
ST405 epidemic genotypes isolated in the study. Our
data are in agreement with previous studies showing
blaVIM-1 carbapenemase into conjugative plasmids
assigned to IncN incompatibility group [43], blaKPC-2
into conjugative plasmids assigned to IncFII incompatibility
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to IncF incompatibility group [37]. However, the pres-
ence of blaKPC-2 carbapenemase into conjugative plas-
mids assigned to IncF incompatibility group has been
described also [41]. The above all data suggest that
conjugation was responsible for carbapenem resist-
ance acquisition in CRE included in the study. The
analysis of antimicrobial resistance profiles of CRE
epidemic genotypes showed that they were microbial-
drug resistant. In particular, we identified CTX-M1
group ESBL in KPC-2 producing ST101 and ST1789
K. pneumoniae isolates and corresponding transconju-
gants. In agreement with our data, the coexistence of
KPC-2 carbapenemase and CTX-M-15 group 1 ESBL
has been demonstrated [12–14]. Also, all 7 K. pneu-
moniae isolates assigned to ST512, 23 out of 25 iso-
lates assigned to ST101, and 8 out 17 isolates
assigned to ST1789 epidemic genotypes were resistant
to aminoglycosides and showed the presence of armA
gene (Additional file 1: Table S1). This is consistent
with previous studies showing the isolation of exten-
sively drug-resistant ArmA-and KPC-2-producing
ST101 K. pneumoniae isolates in Italy [40, 41]. An in-
teresting finding of our study was the occurrence of
colistin resistance in four KPC-2 producing K. pneu-
moniae isolates assigned to ST101/A2-A4 genotypes.
Our data are in agreement with recent studies
showing the emergence of colistin resistance in KPC-2
producing K. pneumoniae isolates from the Netherlands
[44] and KPC-2 or KPC-3 producing K. pneumoniae
isolates from Italy [42, 45, 46]. Because KPC-2 or
KPC-3 producing colistin resistant K. pneumoniae iso-
lates from Italy and the Netherlands belong to ST258
or ST512 single locus variant [42, 44–46], the data
shown herein suggest that colistin resistance may de-
velop in different genetic backgrounds.
Conclusions
The spread of CRE in Valle d’Aosta region was caused
by the selection of KPC-2 producing K. pneumoniae
ST1789 and ST101 isolates, which were single locus
variants and could be assigned to CC101. KPC-2 pro-
ducing K. pneumoniae CC101 were isolated from pa-
tients in geriatrics and other hospital medical wards
and in outpatients in the USL Valle d’Aosta. KPC-3
producing K. pneumoniae ST512 and ST405, and
VIM-1 producing E.coli ST131 were isolated also.
Carbapenem resistance, along with blaKPC-2, blaKPC-3
and blaVIM-1 carbapenemase genes, was transferred by
conjugative plasmids assigned to IncFII, IncF, and
IncN incompatibility groups, respectively, in filter
mating experiments. The emergence of colistin resist-
ance was observed in KPC-2 producing K. pneumo-
niae ST101 isolates.Additional file
Additional file 1: Table S1. Phenotypic and genotypic features of
Enterobacteriaceae included in the study. (XLSX 19 kb)
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